Respiratory
Chiesi has been committed to the development of medicines to treat respiratory diseases for more than 30 years. Thanks to modern treatments, patients with asthma or chronic obstructive pulmonary disease (COPD) have a better chance to live more active lives.
Shish Patel – Medical Director
Shish graduated with a BSc (Hons) in Pharmacy from the University of Sunderland, and post-graduate diploma in Community Pharmacy from Keele University. Over the last 25 years Shish has held various senior positions within the pharmaceutical industry, both Medical Affairs roles at country level, as well as global roles within a commercial environment. A key therapy area of focus during this time has been respiratory.
Dr Rachel Malone – Head of Medical
Rachel graduated from the University of Edinburgh with a BSc (Hons) in Neuroscience in 2001, and from University College London with a PhD in Neuroscience in 2005 [“Nitric Oxide signaling in hippocampal synaptic plasticity”]. Since 2005 she has worked in both pre-clinical and medical affairs roles within the pharmaceutical industry, and has been part of the Chiesi medical team since 2016 across AIR, CARE and RARE.
Dr Matthias Ochel – Medical Science Liaison Manager
Matthias graduated from University of Siegen, Germany with a PhD in Chemistry in 1997 [“Intercalation of lithium into chalcogenides with layered structure”]. After a short period in academic research, he joined the pharmaceutical industry, and has been working within the Chiesi medical department since 2014 (initially as a MSL, and more recently as a MSL manager).
Maryam Nkala – Medical Science Liaison
Maryam graduated from the University of Central Lancashire with a Master’s in Pharmacy in 2012, after which she spent a few years in community pharmacy. She made a move into the pharmaceutical industry in 2016, initially as a sales representative before moving to her first MSL role in 2018. More recently Maryam has joined the Chiesi team as a respiratory MSL in 2023.
Dr Sasha Stimpson – Medical Science Liaison
Sasha graduated from the University of Sheffield in 2018 with a PhD in Chemistry [“Biophysical studies of a novel family of iridium complexes“] before joining the pharmaceutical industry as a respiratory account executive at Chiesi. She later moved to the medical team as a Medical Advisor in 2021 and has since taken up the role as a respiratory MSL.
Lauren Sadler – Medical Science Liaison
Lauren graduated with a BSc (Hons) in Biomedical Sciences from the University of Kent. She completed her dissertation on “The Failings of Drug Discovery: Is Artificial Intelligence and Machine Learning a Solution?” After graduating in 2019, she joined Chiesi as an Account Specialist and has since taken on the role of a respiratory MSL.
Sana Yaar – Medical Science Liaison
Sana graduated from the University of Manchester with a BSc (Hons) in Biomedical Science in 2018, and a PhD in Cardiovascular Science in 2023. Following completion of her PhD, Sana worked as a medical affairs professional across a range of different therapeutic areas. Sana joined Chiesi as a MSL in the respiratory team in 2025.
Tamsin Grewal
Tamsin graduated from the University of Sheffield with a BSc in Molecular Biology in 2018, and an MSc in Molecular Medicine in 2019. After graduating, she worked in medical communications for six years across a range of different therapeutic areas before joining Chiesi as an MSL in April 2026.
Neonatology
For nearly 30 years Chiesi has been deeply committed to neonatology. Working alongside the medical community and investing in neonatal research & development, Chiesi’s ultimate mission is to offer innovative and effective treatment options to improve the level of care for preterm babies.
Rob Cain – Head of Medical Special Care
Rob graduated from UCNW in 1994 with a BSc (Hons) degree in Marine Biology and Chemical Oceanography. He has since spent the last 28 years in a variety of roles across both the commercial and medical sides of the pharmaceutical industry, with specialities ranging from respiratory, cardiovascular disease, metabolic diseases and lysosomal storage disorders. Rob joined the Chiesi medical team in 2022 focussing on neonatology and special care.
Abbey Forster – Medical Science Liaison
Abbey graduated from the University of Manchester with a Master of Pharmacy (Mpharm) and post graduate clinical diploma (PGClinDip), and a non-medical prescribing qualification from the University of Bolton. She spent 9 years practising as a paediatric hospital pharmacist, before transitioning to the pharmaceutical industry in 2024 as a neonatology MSL.
Trishna Patel – Medical Science Liaison
Trishna graduated with a Master of Pharmacy degree in 2015 and went on to complete a Postgraduate Clinical Diploma in General Pharmacy Practice and an Independent Prescribing qualification. She has held a variety of clinical and strategic roles across primary, secondary care and academia before joining the Chiesi medical team in 2025 a neonatology MSL.
Andrew Milton – Medical Science Liaison
Andrew graduated from the University of Kent with BSc (Hons) in Biomedical Sciences in 2013, and MSc (Hons) in Pharmaceutical Drug Design in 2014. He joined Chiesi in 2016 and spent 7 years working across various commercial roles in respiratory. In 2023, Andrew joined the Chiesi medical team as the cardiovascular MSL.
Rare Diseases
Chiesi Global Rare Diseases is committed to the research and development of innovative treatments for people living with rare and ultra-rare diseases, many of whom have limited or no treatments available.
Dr Kamran Iqbal – Head of Medical Affairs
Kamran graduated from St Georges Hospital Medical School in 2003 with a BSc in Basic Medical Sciences. Since graduating he is a member of the Royal College of Physicians (UK), and has gathered clinical experience across various specialities including general medicine, nephrology, dermatology and cardiology. Kamran made the move to the pharmaceutical industry in 2012 and joined Chiesi UK as Head of Medical Affairs for the rare diseases portfolio in 2023.
Phil Dawson – Medical Science Liaison
Phil graduated from the University of Leeds in 1994 with a BSc (Hons) degree in Biochemistry & Genetics. After a brief spell in clinical research he joined the pharmaceutical industry, initially in commercial roles before moving to the medical side and specialising in rare, genetic diseases.
Dr Sogol Salamipour – Medical Advisor
Sogol graduated with a Master of Pharmacy degree from King’s College London in 2015 and spent some time practising as a clinical hospital pharmacist. Sogol then went on to obtain a PhD in Molecular Biology at King’s College London before joining the Chiesi medical team in 2021 as a MSL in the special care team. In October 2023, she moved into the rare disease team as a Medical Advisor.
Matthew Bolz-Johnson
Matt began his NHS career as a hospital manager and worked across NHS commissioning, elective care and cancer services, later becoming National Commissioner for highly specialised services. In 2014, Matt became a patient advocate, working at EURORDIS and Rare Diseases International, where he led the development of the European Reference Networks and public affairs activities on Advanced Therapies and Mental Health. Matt subsequently joined Chiesi UK as Patient Advocacy & Public Affairs Lead for rare diseases.
Special Care
Chiesi is also focussing its attention on the treatment and care of patients suffering from chronic severe conditions, which can be potentially life threatening: Cystic Fibrosis and Solid Organ Transplantation.
Rob Cain – Head of Medical Affairs Special Care
Rob graduated from UCNW in 1994 with a BSc (Hons) degree in Marine Biology and Chemical Oceanography. He has since spent the last 28 years in a variety of roles across both the commercial and medical sides of the pharmaceutical industry, with specialities ranging from respiratory, cardiovascular disease, metabolic diseases and lysosomal storage disorders. Rob joined the Chiesi medical team in 2022 focussing on neonatology and special care.
Danielah Prescott – Medical Science Liaison
Danielah graduated from the University of Manchester with a First Class MSc in Neuroscience in 2020, completing her research on proteomic profiling in glioma progression. She went on to gain experience in laboratory research and diagnostics before joining Chiesi in 2023 as a Medical Advisor in cystic fibrosis and transplantation. Later that year, she moved into her current role as a MSL in special care.